Summit Therapeutics Inc.
SMMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$232 | -$566 | -$63 | -$61 |
| Dep. & Amort. | $0 | -$1 | -$3 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $479 | $11 | $11 |
| Change in WC | $8 | $21 | -$6 | -$1 |
| Other Non-Cash | $129 | -$0 | -$0 | $2 |
| Operating Cash Flow | -$95 | -$67 | -$61 | -$49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$149 |
| Inv. Sales/Matur. | -$1 | $151 | $161 | $233 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $151 | $160 | $83 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$25 |
| Stock Issued | $35 | $3 | $8 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $1 |
| Financing Cash Flow | $35 | $2 | $8 | -$24 |
| Forex Effect | $2 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$59 | $86 | $107 | $11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $298 | $212 | $105 | $94 |
| End Cash | $239 | $298 | $212 | $105 |
| Free Cash Flow | -$95 | -$67 | -$62 | -$49 |